ADENTRA (TSE:ADEN – Get Free Report) had its target price reduced by analysts at Scotiabank from C$49.00 to C$43.00 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock.
A number of other analysts have also weighed in on ADEN. National Bankshares cut their target price on shares of ADENTRA from C$60.00 to C$53.00 in a research note on Monday. Raymond James set a C$60.00 target price on shares of ADENTRA and gave the stock a “strong-buy” rating in a research report on Friday, December 20th. Cormark cut their target price on shares of ADENTRA from C$55.00 to C$46.00 in a research report on Monday. Finally, CIBC reduced their price target on ADENTRA from C$49.00 to C$44.00 and set an “outperform” rating on the stock in a research note on Monday. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $48.13.
Read Our Latest Stock Analysis on ADENTRA
ADENTRA Price Performance
About ADENTRA
ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.
Further Reading
- Five stocks we like better than ADENTRA
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Occidental Petroleum: 4 Reasons to Love These Prices
- How to Use the MarketBeat Excel Dividend Calculator
- Super Micro’s International Presence Makes It a Winning Stock
- What Are Dividends? Buy the Best Dividend Stocks
- Grocery Outlet Insider and Institutional Buyers Signal Bottom
Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.